AMA announces new trustees

The American Medical Association has elected its new board of trustees for 2019-2020, with women physicians as the highest elected officers for the first time.

Patrice Harris, MD, was recently sworn in as the 174th president of the association, while Susan Bailey, MD, is the AMA’s new president-elect and will assume the role in 2020. In addition, Jesse Ehrenfeld, MD, was named the new chair of the board of trustees during the AMA’s annual meeting in Chicago in June.

The board of trustees members are elected by physicians and medical students who gathered at the annual meeting for the AMA’s House of Delegates, its policy-making branch.

Other officers on the board of trustees include:

  • S. Bobby Mukkamala, MD, an otolaryngologist from Flint, Michigan, the newly elected secretary
  • Jack Resneck, Jr., MD, a dermatologist from San Rafael, California, the newly installed immediate past chair
  • Bruce A. Scott, MD, an otolaryngologist from Louisville, Kentucky, the newly elected speaker of the AMA House of Delegates

Beyond the main officers, the association named newly elected members to the board:

  • Grayson W. Armstrong, MD, MPH, an ophthalmology medical resident at Harvard Medical School in Cambridge, Massachusetts
  • Lisa Bohman Egbert, MD, an OB-GYN from Dayton, Ohio, is also the newly elected vice speaker of the AMA House of Delegates.
  • Sarah Mae Smith, a medical student at University of California, Irvine's School of Medicine
  • Michael Suk, MD, JD, MPH, MBA, an orthopaedic surgeon based in Danville, Pennsylvania
  • Willie Underwood, III, MD, MPH, a urologist based in Buffalo, New York
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.